128 related articles for article (PubMed ID: 16937480)
1. Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C.
Zandieh I; Adenwalla M; Cheong-Lee C; Ma PE; Yoshida EM
World J Gastroenterol; 2006 Aug; 12(30):4908-10. PubMed ID: 16937480
[TBL] [Abstract][Full Text] [Related]
2. Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C.
Watanabe M; Ogasawara S; Takahashi A; Takada J; Tanaka Y; Okuwaki Y; Minamino T; Hidaka H; Nakazawa T; Shibuya A; Koizumi W
Cutan Ocul Toxicol; 2012 Sep; 31(3):253-7. PubMed ID: 22172047
[TBL] [Abstract][Full Text] [Related]
3. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
[No Abstract] [Full Text] [Related]
4. Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C.
Goncalves LL; Farias AQ; Gonçalves PL; D'Amico EA; Carrilho FJ
World J Gastroenterol; 2006 Jul; 12(28):4602-3. PubMed ID: 16874884
[TBL] [Abstract][Full Text] [Related]
5. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication.
Ortega-Ibarra FS; Remes-Troche JM
Rev Esp Enferm Dig; 2013; 105(5):291-2. PubMed ID: 23971660
[No Abstract] [Full Text] [Related]
6. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.
Terrier B; Lapidus N; Pol S; Serfaty L; Ratziu V; Asselah T; Thibault V; Souberbielle JC; Carrat F; Cacoub P
World J Gastroenterol; 2015 May; 21(18):5647-53. PubMed ID: 25987791
[TBL] [Abstract][Full Text] [Related]
7. [Acute loss of vision during therapy of chronic hepatitis C].
Salgado JP; Khoramnia R; Maier MM; Lohmann CP; Winkler von Mohrenfels C
Ophthalmologe; 2011 Jun; 108(6):561-4. PubMed ID: 21271253
[TBL] [Abstract][Full Text] [Related]
8. Outcome of antiviral treatment in patients with chronic genotype 1 HCV hepatitis. A retrospective study in 507 patients.
Sporea I; Sirli R; Curescu M; Gheorghe L; Popescu A; Bota S; Iacob S
J Gastrointestin Liver Dis; 2010 Sep; 19(3):261-4. PubMed ID: 20922189
[TBL] [Abstract][Full Text] [Related]
9. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy.
Wong VK; Cheong-Lee C; Ford JA; Yoshida EM
World J Gastroenterol; 2005 Sep; 11(34):5392-3. PubMed ID: 16149154
[TBL] [Abstract][Full Text] [Related]
10. Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.
Wang LJ; Chen SW; Chen CK; Yen CL; Chang JJ; Lee TS; Liu CJ; Chen LW; Chien RN
BMC Psychiatry; 2016 Nov; 16(1):424. PubMed ID: 27884134
[TBL] [Abstract][Full Text] [Related]
11. [Central vein occlusion in a patient using interferon and ribavirin: case report].
Helal J; Zacharias LC; de Alencar LM
Arq Bras Oftalmol; 2006; 69(4):601-4. PubMed ID: 17119740
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
Tsang OT; Zee JS; Chan JM; Li RS; Kan YM; Li FT; Lo FH; Chow DA; Cheung KW; Chan KH; Yeung YW; Ng FH; Li MK; Kwan WK; Lai TS
J Gastroenterol Hepatol; 2010 Apr; 25(4):766-71. PubMed ID: 20492332
[TBL] [Abstract][Full Text] [Related]
13. [A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C].
Shin MK; Kim TH; Ju K; Ha CY; Min HJ; Jung WT; Lee OJ
Korean J Hepatol; 2009 Sep; 15(3):370-4. PubMed ID: 19783887
[TBL] [Abstract][Full Text] [Related]
14. [Acute portal thrombosis in patients with hepatitis C treated with pegylated interferon and ribavirin].
Merino Rodríguez B; Díaz Sánchez A; Matilla Peña A; Clemente Ricote G; Núñez Martínez O
Gastroenterol Hepatol; 2008 Jan; 31(1):18-21. PubMed ID: 18218275
[TBL] [Abstract][Full Text] [Related]
15. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients.
Ronzoni L; Aghemo A; Rumi MG; Prati G; Colancecco A; Porretti L; Monico S; Colombo M; Cappellini MD
J Viral Hepat; 2014 Jun; 21(6):416-23. PubMed ID: 24750239
[TBL] [Abstract][Full Text] [Related]
17. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
Iferkhass S; Elasri F; Chatioui S; Khoyaali A; Bargach T; Reda K; Oubaaz A
J Fr Ophtalmol; 2015 Jan; 38(1):34-40. PubMed ID: 25533994
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C.
Hu CC; Lin CL; Kuo YL; Chien CH; Chen SW; Yen CL; Lin CY; Chien RN
Aliment Pharmacol Ther; 2013 Jan; 37(1):81-90. PubMed ID: 23121150
[TBL] [Abstract][Full Text] [Related]
19. Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
Leung Y; Urbanski SJ; Schindel L; Myers RP
Can J Gastroenterol; 2006 Oct; 20(10):661-3. PubMed ID: 17066158
[TBL] [Abstract][Full Text] [Related]
20. Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial.
Suzuki H; Takagi H; Sohara N; Kanda D; Kakizaki S; Sato K; Mori M;
World J Gastroenterol; 2006 Feb; 12(8):1265-9. PubMed ID: 16534882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
